Malignant Hyperthermia Awareness and Training Month is observed every March, focusing on the critical need for preparedness in handling malignant hyperthermia (MH), a genetic disorder that can cause severe reactions to certain anesthesia drugs. This observance, founded by the Malignant Hyperthermia Association of the United States (MHAUS), aims to educate healthcare professionals and the public about recognizing symptoms early and responding promptly to prevent severe complications or death. Typical actions during this month include hosting educational workshops, social media campaigns, fun runs or walks, and community events like quiz nights and storytime sessions to raise awareness. The initiative also encourages hospitals to maintain adequate supplies of dantrolene, the life-saving drug used to treat MH episodes, and supports ongoing research to improve management and outcomes for affected individuals.